Clinical Trials in Tyumen, Tyumen Oblast
2 recruiting
Showing 1–2 of 2 trials
Recruiting
Phase 3
Long-term Safety and Efficacy Extension Study for Participants With Advanced Tumors Who Are Currently on Treatment or in Follow-up in a Pembrolizumab (MK-3475) Study (MK-3475-587/KEYNOTE-587)
Solid TumorsHematologic Malignancies
Merck Sharp & Dohme LLC3,500 enrolled779 locationsNCT03486873
Recruiting
Not Applicable
Gepaktiv vs UDCA and Ademetionine in MAFLD With Hepatomegaly
Fatty Liver DiseaseHepatomegalyFatty Liver+5 more
Phenomen Pharma90 enrolled1 locationNCT07068191